Emmanouil Kontopodis

Author

University Hospital of Heraklion

Also Known As

E Kontopodis, E. Kontopodis, Emmanouil Kontopodis

Publications

396

Citations

H-Index

Concepts

All Affiliations

University Hospital of Heraklion Hellenic Oncology Research Group University of Crete University General Hospital Attikon National and Kapodistrian University of Athens

About

Emmanouil Kontopodis is an author at University Hospital of Heraklion specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	78
2	Cancer Therapeutics	3	3	59
3	Pharmacology	2	2	29
4	Pathology	1	1	19
5	Hematology	1	1	19

Emmanouil Kontopodis

Publications

303

Citations

H-Index

Page 1

	Year	Citations
Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer Anna Daskalaki, Sofia Agelaki, Maria Perraki, British Journal of Cancer	2009	99
A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group Emmanouil Kontopodis, Dora Hatzidaki, Ioannis Varthalitis, Journal of Chemotherapy	2013	48
Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: A phase II multicenter study of the Hellenic Oncology Research Group Giannis Mountzios, Christos Emmanouilidis, N. Vardakis, Lung Cancer OncologySalvage TreatmentMetronomic TherapyBronchial NeoplasmCancer Treatment	2012	37
A Comprehensive Molecular Analysis of in Vivo Isolated EpCAM-Positive Circulating Tumor Cells in Breast Cancer Αreti Strati, Martha Zavridou, Galatea Kallergi, Clinical Chemistry	2021	24
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies Prithviraj Bose, Edward Brent Perkins, Connie Honeycut, Cancer Chemotherapy and Pharmacology Hematological MalignancyMedicineMalignant Blood DisorderHematologyPharmacology	2012	19
Endocarditis caused by Gemella morbillorum resistant to β-lactams and aminoglycosides Diamantis P. Kofteridis, T. Anastasopoulos, Symeon Panagiotakis, Scandinavian Journal of Infectious Diseases	2006	18
Effect of Osimertinib on CTCs and ctDNA in EGFR Mutant Non-Small Cell Lung Cancer Patients: The Prognostic Relevance of Liquid Biopsy Galatea Kallergi, Emmanouil Kontopodis, Aliki Ntzifa, Cancers	2022	18
Evaluation of Febrile Neutropenia in Hospitalized Patients with Neoplasia Undergoing Chemotherapy Maria Bachlitzanaki, G Aletras, E Bachlitzanaki, Microorganisms	2023	18
Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG) Ourania Katopodis, John Souglakos, E. Stathopoulos, Cancer Chemotherapy and Pharmacology UrologyPancreatic CancerGastrointestinal OncologyMedicinePharmacotherapy	2014	12
Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer Emmanouil Kontopodis, Nikolaos Kentepozidis, C. Christophyllakis, Cancer Chemotherapy and Pharmacology Salvage ChemotherapyBreast OncologyOncologyPharmacologyBreast Cancer	2014	10

Page 1